Proto Labs Inc. (PRLB) intrinsic value & 10-year financials
Proto Labs Inc. (PRLB) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 6.7% a year to $533.1M, with an average return on invested capital of 5.7%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $85.65
- Market cap
- $2.1B
- Revenue (FY2025)
- $533.1M
- Revenue growth (10-yr CAGR)
- 6.7%
- ROIC (10-yr avg)
- 5.7%
- Free cash flow (FY2025)
- $59.7M
PRLB 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $533.1M | $21.2M | $0.88 | $59.7M | 4.7% | 3.0% |
| FY2024 | $500.9M | $16.6M | $0.66 | $68.7M | 4.0% | 2.2% |
| FY2023 | $503.9M | $17.2M | $0.66 | $45.2M | 5.6% | 2.8% |
| FY2022 | $488.4M | -$103.5M | -$3.77 | $40.4M | -20.1% | -13.9% |
| FY2021 | $488.1M | $33.4M | $1.21 | $21.0M | 8.3% | 5.2% |
| FY2020 | $434.4M | $50.9M | $1.89 | $60.0M | 13.8% | 9.7% |
| FY2019 | $458.7M | $63.7M | $2.35 | $53.8M | 17.4% | 13.5% |
| FY2018 | $445.6M | $76.6M | $2.81 | $35.8M | 20.0% | 16.8% |
| FY2017 | $344.5M | $51.8M | $1.93 | $49.1M | 21.0% | 11.7% |
| FY2016 | $298.1M | $42.7M | $1.61 | $43.9M | 20.7% | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Proto Labs Inc has demonstrated mature, steady growth, with revenue compounding at 6.7% annually over the past decade.
Proto Labs Inc has historically struggled to out-earn its cost of capital, averaging just 5.7% ROIC.
Proto Labs Inc has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Proto Labs Inc is modeled at -6.5% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-3.40 per share.